Treatment of Pediatric Migraine

被引:22
|
作者
O'Brien, Hope L. [1 ,2 ]
Kabbouche, Marielle A. [1 ,2 ]
Kacperski, Joanne [1 ,2 ]
Hershey, Andrew D. [1 ,2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA
关键词
Pediatric migraine; Primary headache; Treatment; NSAIDs; Triptans; Dopamine antagonists; DHE; Nutraceuticals; Chronic migraine; DOUBLE-BLIND; CHILDHOOD MIGRAINE; EMERGENCY-DEPARTMENT; PHARMACOLOGICAL-TREATMENT; SODIUM VALPROATE; DOSE RIBOFLAVIN; NASAL SPRAY; PLACEBO; CHILDREN; PROPHYLAXIS;
D O I
10.1007/s11940-014-0326-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The diagnosis of migraine in the pediatric population is increasing as providers are becoming more familiar with recognizing the condition. Over-the-counter and migraine-specific treatment, once considered off-label, have proven to be effective, especially if given at the early onset of head pain. Mild to severe cases of migraine should be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), with triptans used alone or in combination in moderate to severe headaches unresponsive to over-the-counter therapy. Rescue medication including dihydroergotamine (DHE), a potent vasoconstrictor should be used for intractable migraines and is preferred in the hospital setting. Anti-emetics that have anti-dopaminergic properties can be helpful in patients with associated symptoms of nausea and vomiting along with headache, especially when used in combination therapy. Preventative treatment should be initiated early in patients with frequent headaches to improve headache outcomes and quality of life. Patients and families should be educated on non-pharmacologic management, such as lifestyle modification and avoidance of triggers, that can prevent progression and worsening of migraine.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [21] Acute Migraine Headache: Treatment Strategies
    Mayans, Laura
    Walling, Anne
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (04) : 243 - 251
  • [22] Further Evidence that Onabotulinum ,Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients
    Ali, Sameer S.
    Bragin, Ilya
    Rende, Elizabeth
    Mejico, Luis
    Werner, Klaus E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (03)
  • [23] Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis A Systematic Review and Network Meta-analysis
    Locher, Cosima
    Kossowsky, Joe
    Koechlin, Helen
    Lam, Thanh Lan
    Barthel, Johannes
    Berde, Charles B.
    Gaab, Jens
    Schwarzer, Guido
    Linde, Klaus
    Meissner, Karin
    JAMA PEDIATRICS, 2020, 174 (04) : 341 - 349
  • [24] Management of Pediatric Migraine: Current Therapies
    Khrizman, Marina
    Pakalnis, Ann
    PEDIATRIC ANNALS, 2018, 47 (02): : E55 - E60
  • [25] Pediatric migraine: Pharmacologic agents for prophylaxis
    Eiland, Lea S.
    Jenkins, Lauren S.
    Durham, Spencer H.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (7-8) : 1181 - 1190
  • [26] Treatment of Pediatric Migraine in the Emergency Room
    Gelfand, Amy A.
    Goadsby, Peter J.
    PEDIATRIC NEUROLOGY, 2012, 47 (04) : 233 - 241
  • [27] Migraine treatment in developmental age: guidelines update
    Papetti, Laura
    Spalice, Alberto
    Nicita, Francesco
    Paolino, Maria Chiara
    Castaldo, Rosa
    Iannetti, Paola
    Villa, Maria Pia
    Parisi, Pasquale
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 (03): : 267 - 276
  • [28] Acute Treatment of Migraine
    Tepper, Stewart J.
    NEUROLOGIC CLINICS, 2019, 37 (04) : 727 - +
  • [29] Pediatric Migraine An Update
    Greene, Kaitlin
    Irwin, Samantha L.
    Gelfand, Amy A.
    NEUROLOGIC CLINICS, 2019, 37 (04) : 815 - +
  • [30] Dihydroergotamine: role in the treatment of migraine
    Schuerks, Markus
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (09) : 1141 - 1148